TEICOPLANIN PLUS CIPROFLOXACIN VERSUS GENTAMICIN PLUS PIPERACILLIN IN THE TREATMENT OF FEBRILE NEUTROPENIC PATIENTS

Teicoplanin plus ciprofloxacin was compared with gentamicin plus piperacillin for the empirical treatment of fever in 80 neutropenic patients. A favourable response was seen in 78 % of patients receiving teicoplanin plus ciprofloxacin and in 49 % receiving gentamicin plus piperacillin (p < 0.05). When microbiologically documented episodes were analysed separately, the response to teicoplanin plus ciprofloxacin was favourable in 81 % of patients whereas only 35 % responded favourably to gentamicin plus piperacillin (p = 0.034). Gram-positive organisms accounted for 76 % of bacterial isolates, Staphylococcus epidermidis being the most common pathogen. Ten of 12 (83 %) Staphylococcus epidermidis infections resolved when treated with teicoplanin plus ciprofloxacin as compared with 2 of 8 (25 %) treated with gentamicin plus piperacillin. Teicoplanin is at least as effective as gentamicin plus piperacillin in the empirical treatment of febrile neutropenic patients and may be more effective in situations where gram-positive organisms are prevalent. The high incidence of gram-positive infections in our unit justifies the use of an agent with specific activity against gram-positive organisms in the first-line antibiotic regimen.